Asthma

New data shows nearly 40% of chronic lung disease patients from a Portuguese hospital died within 5 years of initiating respiratory rehabilitation.

Patients saw improvement in symptom perception, activity limitation, emotional function, and environmental stimuli.

Obese-related asthma is considered one of the more severe asthma phenotypes.

The added indication makes the GSK single inhaler triple therapy the first of its kind approved for both asthma and COPD in the US.

Telemedicine has become an important tool during the COVID-19 pandemic.

Problems using inhalers correctly is an ongoing issue for both pediatric and adult patients.

A $25 genetic test could inform physicians on optimal controller therapy for children and adolescents with asthma.

In a new study presented at ERS 2020, Dr. Mark Levy discusses how a digital inhaler reduces the amount of people who use their inhaler incorrectly.

The risk of cardiovascular hospitalizations was associated with increasing PM10 at lag 0.

In a poster presented at the ERS Virtual Conference, investigators identify the relative rate of severe asthma exacerbations using LAMA monotherapy.

In the placebo-controlled study, both treatment groups experienced similar rates of severe asthma worsening and mean time to exacerbation.

At least 2 hours of follow-up with a healthcare provider is effective at reducing healthcare use and improving the quality of life in patients with asthma.

There are several factors, both environmental and familial, that are associated with a higher risk of developing asthma and persistent wheezing.

There was no observed difference in proportion of disease progression between sildenafil combined with pirfenidone and placebo treatment groups.

Data suggests treatment with the palliative opioid does not affect PCO2 levels, suggesting it is safe in patients with moderate to severe COPD.

Results of ANDHI provide additional support on the safety and efficacy of benralizumab for patients with asthma.

Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.

In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.

A new case study  assesses biopsy and autopsy tissues to characterize pathological patterns in suspected EVALI cases .

In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.

A one-time intramuscular dose of the investigative drug was linked to reduced medical attention and hospitalizations related to RSV.

New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients.

There is also an association between late onset of spring and an increase in hospital admissions for asthma.

ADHD, autism spectrum disorder, seizures, and even developmental delays are asssociated with a two-fold risk of asthma in US children.

The FDA is allowing the pen to be used for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis (CRSwNP) patients at least 12 years old.